Effective Dec. 1, 2022, Medicaid and NC Health Choice cover teplizumab-mzwv injection.
Topics Related to Physicians, Physician Assistants and Nurse Practitioners
Effective Nov. 16, 2022, Medicaid and NC Health Choice cover tremelimumab-actl injection.
Effective Dec. 15, 2022, Medicaid and NC Health Choice cover mirvetuximab soravtansine-gynx injection.
Note: This bulletin is replaced by NC Health Choice Move to Medicaid: Timeline for Claims Adjudication and Process for Prior Approvals.
Effective with date of service Nov. 15, 2022, Medicaid and NC Health Choice cover Eflapegrastim-xnst injection, for subcutaneous use (Rolvedon).
Effective with date of service Oct. 19, 2022, Medicaid and NC Health Choice cover Sodium Thiosulfate injection, for intravenous use (Pedmark).
Effective with date of service Oct. 3, 2022, Medicaid and NC Health Choice cover Ranibizumab-eqrn injection, (Cimerli)
Indigotindisulfonate Sodium Injection, for Intravenous Use (Bludigo™) HCPCS Code: Billing Guidelines
Effective with date of service Sept 30, 2022, Medicaid and NC Health Choice cover Indigotindisulfonate sodium injection (Bludigo)
Effective with date of service Oct. 5, 2022, Medicaid and NC Health Choice cover Bevacizumab-maly injection (Alymsys)
Effective with date of service August 31, 2022, Medicaid and NC Health Choice cover Pfizer-BioNTech COVID-19 Vaccine